Erythromycin
Product Images NDC 53002-9050

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 53002-9050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Erythromycin (structural Formula) (Image 01)

Chemical structure diagram of erythromycin shown with carbon, hydrogen, oxygen, and nitrogen atoms arranged in a complex macrolide ring structure. The molecule includes cyclic ethers, hydroxyl groups, and methyl substitutions, illustrating the core architecture of erythromycin.*

FDA Label Image

Label Image (Lbl530029050)

Erythromycin Ophthalmic Ointment 0.5% sterile, manufactured by RPK Pharmaceuticals, Inc. The label includes usage instructions to apply to affected eyes 3 to 4 times daily or as directed. It also shows patient name and clinic name fields, lot number, expiration date, and barcode information on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.